Menu
Search
|

Menu

Close
X

Novartis AG NOVN.S (Virt-X Level 1)

74.64 CHF
+1.20 (+1.63%)
As of 11:31 AM EDT
chart
Previous Close 73.44
Open 73.66
Volume 3,523,008
3m Avg Volume 5,288,371
Today’s High 74.64
Today’s Low 73.46
52 Week High 88.30
52 Week Low 72.68
Shares Outstanding (mil) 2,550.62
Market Capitalization (mil) 187,982.09
Forward P/E 21.75
Dividend (Yield %) 2.80 ( 3.81 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.39 Mean rating from 28 analysts

KEY STATS

Revenue (mm, USD)
FY18
12,929
FY17
50,135
FY16
49,386
FY15
50,359
EPS (USD)
FY18
0.863
FY17
3.226
FY16
2.798
FY15
2.874
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
21.75
33.54
Price to Sales (TTM)
vs sector
3.70
8.28
Price to Book (MRQ)
vs sector
2.42
4.21
Price to Cash Flow (TTM)
vs sector
13.98
22.70
Total Debt to Equity (MRQ)
vs sector
47.98
17.68
LT Debt to Equity (MRQ)
vs sector
32.63
13.20
Return on Investment (TTM)
vs sector
7.52
13.09
Return on Equity (TTM)
vs sector
11.54
15.10

EXECUTIVE LEADERSHIP

Joerg Reinhardt
Independent Non-Executive Chairman of the Board, Since 2013
Salary: --
Bonus: --
Chris Ilsley
President, Chief Executive Officer, Since 2018
Salary: --
Bonus: --
Enrico Vanni
Independent Non-Executive Vice Chairman of the Board, Since 2013
Salary: --
Bonus: --
Harry Kirsch
Chief Financial Officer, Member of the Executive Committee, Since 2013
Salary: --
Bonus: CHF800,814.00
Elizabeth Barrett
CEO, Novartis Oncology, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Lichtstrasse 35
BASEL     4056

Phone: +4161.3241111

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

SPONSORED STORIES